We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ASML
ASML
$596B
| $43.5M | 0.81% |
+62,959
| New | +$41.5M |
|
|
27
Regeneron Pharmaceuticals
REGN
$72.9B
| $43.5M | 0.81% |
77,859
-108,040
| -58% | -$54.7M |
|
28
Snap
SNAP
$7.96B
| $41.5M | 0.77% |
+609,604
| New | +$36.6M |
|
29
Omnicom Group
OMC
$22.7B
| $40M | 0.75% |
+499,789
| New | +$40.6M |
|
30
Immunovant
IMVT
$7.93B
| $39.6M | 0.74% |
3,750,575
+2,853,958
| +318% | +$39.8M |
|
|
NATI
31
DELISTED
National Instruments Corp
NATI
| $39.2M | 0.73% |
926,485
+138,859
| +18% | +$5.85M |
|
32
Ionis Pharmaceuticals
IONS
$8.93B
| $38.4M | 0.72% |
963,788
+487,897
| +103% | +$19.1M |
|
33
Lyft
LYFT
$5.86B
| $38.2M | 0.71% |
632,009
+187,329
| +42% | +$10.8M |
|
34
Neurocrine Biosciences
NBIX
$18.2B
| $37.5M | 0.7% |
+385,054
| New | +$36.9M |
|
|
DRNA
35
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $37.3M | 0.7% |
1,000,325
-776,675
| -44% | -$23.8M |
|
36
Eli Lilly
LLY
$1.08T
| $36.2M | 0.67% |
157,691
+42,045
| +36% | +$8.45M |
|
37
Skyworks Solutions
SWKS
$9.21B
| $35.8M | 0.67% |
+186,770
| New | +$33.1M |
|
|
38
Danaher
DHR
$138B
| $35.8M | 0.67% |
150,345
-298,091
| -66% | -$66.1M |
|
39
AT&T
T
$164B
| $35M | 0.65% |
1,611,462
+1,271,107
| +373% | +$28.9M |
|
40
Fidelity National Information Services
FIS
$24.2B
| $34.2M | 0.64% |
241,613
-256,511
| -51% | -$38.1M |
|
41
Vertex Pharmaceuticals
VRTX
$123B
| $33.1M | 0.62% |
164,064
-50,012
| -23% | -$10.5M |
|
42
Edwards Lifesciences
EW
$49.4B
| $31.8M | 0.59% |
+307,190
| New | +$29M |
|
43
Avantor
AVTR
$9.73B
| $31M | 0.58% |
873,832
-68,112
| -7% | -$2.2M |
|
44
Merck
MRK
$322B
| $30.1M | 0.56% |
386,894
+87,842
| +29% | +$6.53M |
|
|
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $28.7M | 0.54% |
+420,953
| New | +$27.4M |
|
|
KLRS
46
Kalaris Therapeutics
KLRS
$80.9M
| $28.1M | 0.52% |
61,995
+10,694
| +21% | +$5.52M |
|
47
SkinHealth Systems
SKIN
$83.4M
| $27.4M | 0.51% |
+1,628,416
| New | +$22.3M |
|
48
Western Digital
WDC
$159B
| $27.2M | 0.51% |
505,172
+223,526
| +79% | +$12.1M |
|
49
Revolution Medicines
RVMD
$38.5B
| $27M | 0.5% |
851,592
+9,530
| +1% | +$333K |
|
50
Zentalis Pharmaceuticals
ZNTL
$332M
| $26.9M | 0.5% |
505,675
+361,514
| +251% | +$19.4M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.